NA
Last reporting period 31 Dec, 2022
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.174
Exchange
XNAS - Nasdaq
0.0087 B
Last period FCFE ,USD
What is FCFE ?
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
See also NewAmsterdam Pharma
Company Analysis
NAMS valuation, rating, competitors, insights and company profile
Eyestock Rating
NAMS financial analysis by Eyestock methodology
Valuation
NAMS valuation using historical relative method
Statements
NAMS Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NAMS dividend yield and annual dividend
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
NewAmsterdam Pharma`s FCFE for the period ended 2022-12-31 is 0.0087 B USD
